From: Access to artemisinin combination therapy for malaria in remote areas of Cambodia
Antimalarial therapy received (%) | Intervention area % (n) | ||
---|---|---|---|
 | None n = 224 | Outreach n = 78 | VMW n = 21 |
Artesunate + mefloquine | 11% (29) | 23% (18) | 52% (13) |
Artemisinin derivative +/- other antimalarial | 40% (102) | 13% (10) | 5% (1) |
Quinine +/- other antimalarial | 9% (22) | 12% (9) | 0 |
Chloroquine +/- other antimalarial | 24% (62) | 38% (30) | 0 |
Unknown | 16% (42) | 14% (11) | 33% (7) |